	US 11,806,419 B2
	Aptamers for odor control applications
Juan Esteban Velasquez, Cincinnati, OH (US); Amy Violet Trejo, Mason, OH (US); Gregory Allen Penner, Toronto (CA); and Stevan David Jones, Hyde Park, OH (US)
Assigned to The Procter & Gamble Company, Cincinnati, OH (US)
Filed by The Procter & Gamble Company, Cincinnati, OH (US)
Filed on Apr. 16, 2020, as Appl. No. 16/850,840.
Claims priority of provisional application 62/834,425, filed on Apr. 16, 2019.
Prior Publication US 2020/0330353 A1, Oct. 22, 2020
Int. Cl. A61K 8/60 (2006.01); A61K 8/34 (2006.01); A61Q 15/00 (2006.01)

CPC A61K 8/606 (2013.01) [A61K 8/34 (2013.01); A61Q 15/00 (2013.01)]

8 Claims

1. A personal care composition comprising an aptamer composition comprising at least one oligonucleotide composed of nucleotides selected from the group consisting of: deoxyribonucleotides, ribonucleotides, derivatives of deoxyribonucleotides, derivatives of ribonucleotides, and mixtures thereof;

wherein the aptamer composition comprises at least one oligonucleotide selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2, SEQ ID NO 102, and SEQ ID NO 201.